Artificial Intelligence Versus Anesthesiologist Visual Assessment of Ejection Fraction by Transesophageal Echocardiography During Cardiac Surgery
Reliability of Artificial Intelligent General Application in Assessing Ejection Fraction in Comparison to Anesthesiologist Eye Ball by Trans Oesophageal Echo During Cardiac Surgery
1 other identifier
observational
93
1 country
1
Brief Summary
This prospective observational study evaluated the reliability of a general-purpose artificial intelligence application in estimating left ventricular ejection fraction from intraoperative transesophageal echocardiography images during cardiac surgery. The artificial intelligence estimates were compared with visual assessment by two independent blinded professor anesthesiologists and with preoperative transthoracic echocardiography findings. Ejection fraction measured using M-mode and the time required for each assessment were also evaluated. The study included 93 adults undergoing elective coronary artery bypass grafting or valve surgery. The artificial intelligence assessments were performed using pseudonymized images and were not used to guide clinical decisions or patient management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 22, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
August 22, 2026
CompletedFirst Submitted
Initial submission to the registry
September 14, 2026
CompletedFirst Posted
Study publicly available on registry
September 25, 2026
CompletedSeptember 25, 2026
September 1, 2026
5 months
September 14, 2026
September 20, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference Between AI and Anesthesiologist Visual Assessment of LVEF
Left ventricular ejection fraction was assessed from the same intraoperative transesophageal echocardiography transgastric short-axis mid-papillary view at 0 degrees by a general-purpose artificial intelligence application and by two independent blinded professor anesthesiologists using visual (eyeball) assessment. The paired assessments were compared to evaluate the difference and agreement between the artificial intelligence and anesthesiologist assessments.
During cardiac surgery, at the time of the intraoperative TEE assessment
Secondary Outcomes (3)
Difference Between AI and Anesthesiologist M-Mode Assessment of LVEF
During cardiac surgery, at the time of the intraoperative TEE assessment
Time Required for AI and Anesthesiologist LVEF Assessment
During intraoperative TEE image review, from the start of each visual (eyeball) or M-mode LVEF assessment until the corresponding estimate is completed, assessed up to 3 minutes per assessment per participant.
Difference Between Intraoperative TEE and Preoperative TTE LVEF Assessments
From the available preoperative TTE assessment to the intraoperative TEE assessment during cardiac surgery
Study Arms (1)
Elective Cardiac Surgery Patients
A single cohort of 93 adult patients undergoing elective coronary artery bypass grafting or valve repair or replacement surgery. Intraoperative transesophageal echocardiography images were evaluated for left ventricular ejection fraction using artificial intelligence, anesthesiologist visual assessment, and M-mode echocardiography.
Interventions
Pseudonymized end-diastolic and end-systolic frames and an M-mode recording obtained from the transgastric short-axis mid-papillary view at 0 degrees were analyzed by a general-purpose artificial intelligence application to estimate left ventricular ejection fraction. The artificial intelligence results were compared with assessments by two independent blinded professor anesthesiologists and with preoperative transthoracic echocardiography. The artificial intelligence output was used only for research and did not guide clinical management.
Eligibility Criteria
Adult patients aged 21 years or older who were scheduled for elective coronary artery bypass grafting, valve repair, or valve replacement surgery at the Cardiothoracic Surgery Academy, Ain Shams University and had an available preoperative transthoracic echocardiographic assessment.
You may qualify if:
- Age 21 years or older.
- Scheduled for elective cardiac surgery involving coronary artery bypass grafting, valve repair, or valve replacement.
- Availability of a preoperative transthoracic echocardiographic assessment.
- Either sex.
- American Society of Anesthesiologists physical status III or IV.
You may not qualify if:
- Coagulopathy, defined as an international normalized ratio greater than 2 or a platelet count below 50,000/mm3.
- Previous cardiac surgery (redo procedure).
- Esophageal or upper gastrointestinal pathology preventing safe transesophageal echocardiography probe placement, including esophageal stricture, tumor, or large varices.
- Poor-quality transesophageal echocardiography images despite standard optimization, preventing reliable interpretation.
- Severe arrhythmia or hemodynamic instability before surgery, during induction, or during surgery that could compromise the accuracy of the transesophageal echocardiography assessment.
- Refusal to participate or a condition limiting valid consent or participation, including cognitive impairment or a language barrier.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cardiothoracic Surgery Academy, Ain Shams University Hospitals
Cairo, Cairo Governorate, Egypt
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2026
First Posted
September 25, 2026
Study Start
March 28, 2026
Primary Completion
August 22, 2026
Study Completion
August 22, 2026
Last Updated
September 25, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because external sharing of participant-level data was not included in the approved study protocol, ethics approval, or informed consent. Only aggregate study results will be reported.